SBI Securities’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
SBI Securities's DNTH Position: Q3 2026 in Review
SBI Securities increased its Dianthus Therapeutics (DNTH) stake by 1,300% in Q3 2026, buying an estimated $1.35K and bringing the position to 14 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #2781.
SBI Securities first reported a position in DNTH in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.76K in Q1 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- SBI Securities held 14 shares of Dianthus Therapeutics worth $1.23K as of Q3 2026.
- SBI Securities bought 13 Dianthus Therapeutics shares in Q3 2026, an estimated $1.35K.
- Dianthus Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2781 holding.
- SBI Securities first reported a position in Dianthus Therapeutics in Q4 2024 and has held it in 8 quarters since.
- SBI Securities's Dianthus Therapeutics position peaked at $1.76K in Q1 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.